Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2026-01-07 @ 5:28 AM
Study NCT ID:
NCT03422393
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-05
First Post:
2018-01-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib
Sponsor:
Organization: